Page 1 of Clinical Trials for "Lapatinib", 240 Total Matches
- 1CompletedLast Updated: April 12, 2012Condition(s): Prostate Cancer
- 2RecruitingLast Updated: February 4, 2011Condition(s): BRMS1; Performance Status Zero to Two for Beginning the Study; Patient With a Maximum of One Chemotherapy; Patient With Progression After Taxanes
- 3CompletedLast Updated: April 19, 2012Condition(s): Neoplasms, Breast
- 4WithdrawnLast Updated: February 5, 2009Condition(s): Advanced Solid Tumors
- 5Active, not recruitingLast Updated: April 12, 2012Condition(s): Neoplasms, Breast
- 6TerminatedLast Updated: March 17, 2011Condition(s): Neoplasms, Breast; Breast Cancer
- 7RecruitingLast Updated: March 1, 2012Condition(s): Cancer
- 8TerminatedLast Updated: October 11, 2011Condition(s): Locally Advanced or Metastatic Breast Cancer
- 9RecruitingLast Updated: March 1, 2012Condition(s): Solid Tumors; Neoplasms, Breast; Cancer
- 10RecruitingLast Updated: May 2, 2012Condition(s): GastroEsophageal Cancer
- 11CompletedLast Updated: April 21, 2011Condition(s): Advanced Non-Small Cell Lung Cancer; Lung Cancer, Non-Small Cell
- 12Active, not recruitingLast Updated: April 19, 2012Condition(s): Neoplasms, Breast
- 13TerminatedLast Updated: March 17, 2011Condition(s): Non-Small-Cell Lung Cancer; Lung Cancer, Non-Small Cell
- 14RecruitingLast Updated: May 14, 2012Condition(s): Colorectal Cancer; Lung Cancer; Head and Neck Cancer
- 15Active, not recruitingLast Updated: May 17, 2012Condition(s): Neoplasms, Gastrointestinal Tract
- 16CompletedLast Updated: August 18, 2011Condition(s): Metastatic ErbB2; Neoplasms, Breast; Breast Cancer
- 17CompletedLast Updated: April 17, 2012Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
- 18Enrolling by invitationLast Updated: October 18, 2011Condition(s): Recurrent Endometrial Cancer
- 19Active, not recruitingLast Updated: May 17, 2012Condition(s): Cancer
- 20Active, not recruitingLast Updated: May 17, 2012Condition(s): or Gastro-esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.; ErbB2 (HER2) Amplified Gastric; Neoplasms, Gastrointestinal Tract; Esophageal
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Lapatinib%22
